Nemolizumab rapidly relieves itch and sleep disturbance among patients with moderate-to-severe atopic dermatitis (AD) and ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its ‍experimental drug to treat patients with moderate ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. JNJ, ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

Eczema is a skin condition that people have for a time. It is also known as atopic dermatitis. Eczema makes your skin dry and ...

Adults with atopic eczema are significantly more likely to experience suicidal thoughts than those without the skin condition ...

Côte St. Luc City speaks out on Chanukah massacre in Australia ...

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...